The recent enthusiasm for installing robotic surgical systems in public hospitals across low- and middle-income regions reflects a growing belief that high-end technology can transform healthcare overnight. Policy announcements and hospital briefings often celebrate the introduction of robotic consoles as symbols of advancement, as if acquiring such machines automatically improves the quality of care. But anyone familiar with the reality of public hospitals knows that these celebrations mask a troubling contradiction. In facilities where patients are asked to purchase their own thermometers, cannulae, adhesive tapes or even gowns, the decision to invest in multimillion-dollar robotic systems is not visionary—it is misplaced.
There is no doubt that robotic-assisted surgery represents genuine innovation. It enhances precision, provides 3D visualisation and allows tremor-free motion, offering clear advantages in selected procedures. But such benefits are meaningful only in systems where the basics are reliably in place. In hospitals struggling with inconsistent sterilisation, disrupted supply chains or outdated safety protocols, the promise of robotics becomes symbolic rather than practical. Instead of reducing disparities, it risks reinforcing them.
Supporters of robotic surgery often argue that it boosts outcomes, reduces surgeon fatigue and modernises medical training. These points carry weight in well-resourced settings. But in underfunded public hospitals, the opportunity cost is enormous. A single robotic unit, along with its maintenance contracts and consumables, can drain funds that could otherwise strengthen essential services: ensuring every operating theatre has functioning laparoscopic equipment, guaranteeing uninterrupted oxygen supply or restoring sterilisation units. The issue is not choosing between innovation and stagnation; it is about sequencing priorities responsibly.
Prudent decision-making starts with asking whether there is a clear clinical need and a consistent case volume to justify the machine. It asks whether basic infrastructure—sterile consumables, monitoring equipment, WHO safety checklists—is fully reliable. It demands realistic budgeting not only for procurement but also for maintenance, software updates and consumable parts. It requires trained surgical, anaesthesia, nursing and biomedical engineering teams. It also demands dependable local technical support. Above all, it requires that the technology meaningfully benefits the public patient, not just the affluent few.
In many regions, these conditions simply do not exist. Evidence shows that robotic surgery offers only marginal benefits over laparoscopy for common procedures, while dramatically increasing costs. The prestige associated with high-tech equipment often benefits hospitals and surgeons more than patients. When public money must stretch between drug supplies, critical infrastructure, rural health services and core operating theatre needs, the ethical choice is clear: fix the foundations before reaching for the future.
A more responsible pathway begins with ensuring that no patient is told to buy basic supplies for their own surgery. Once sterilisation services, consumables and safety protocols are sound, hospitals can strengthen laparoscopic capacity—the most cost-effective bridge to advanced surgery. Only then should a state consider piloting robotics in one or two tertiary centres, with transparent evaluation of case volumes, outcomes and costs. Future investments must be guided by data, not prestige. Technology should expand access, not deepen inequity.
Robotics can complement public healthcare only when introduced within a system that is ready to support it. Hospitals that cannot guarantee sterile gloves or reliable electricity should not prioritise surgical robots. Yet the same hospitals can adopt a visionary trajectory by strengthening fundamentals, training staff, modernising inventory systems and improving laparoscopic skills. These steps build the scaffolding on which advanced technology can later stand safely and justifiably.
Ultimately, progress in healthcare is not measured by the sophistication of machines but by the safety, equity and consistency of care they support. Robotic surgery undoubtedly represents a part of the future, but the future must be approached step by step. Skipping essential stages risks wasting precious resources and eroding public trust in healthcare innovation. A mature vision demands that we first build a system where operating rooms are safe, supplies are reliable, decisions are data-driven and every patient—regardless of income—receives dignified, competent care. Only then will a robotic console belong in a public hospital, not as a trophy but as the next logical step toward a more just and efficient healthcare system.
(The author is a healthcare analyst, clinical auditor, surgeon and healthcare policy advisor. Email: [email protected])
Comments are closed.